Found: 32
Select item for more details and to access through your institution.
CD4/CD8 Ratio During Human Immunodeficiency Virus Treatment: Time for Routine Monitoring?
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1688, doi. 10.1093/cid/ciad136
- By:
- Publication type:
- Article
Correction to: Prevalence of Ocular Complications in Candidemia: Defining the "Battlefield".
- Published in:
- 2023
- Publication type:
- Correction Notice
Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Toward Improved Science Communication.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1535, doi. 10.1093/cid/ciad124
- By:
- Publication type:
- Article
Reply to Molldrem.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Research on the Development of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in People With Advanced Human Immunodeficiency Virus Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
In the Literature.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. i, doi. 10.1093/cid/ciad042
- By:
- Publication type:
- Article
Could Home Human Immunodeficiency Virus Self-Testing Ever Become a Game Changer?
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1681, doi. 10.1093/cid/ciad026
- By:
- Publication type:
- Article
Accelerating Human Immunodeficiency Virus Self-Testing in the United States: A Call to Action.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1678, doi. 10.1093/cid/ciad025
- By:
- Publication type:
- Article
Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1655, doi. 10.1093/cid/ciad024
- By:
- Publication type:
- Article
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1646, doi. 10.1093/cid/ciad020
- By:
- Publication type:
- Article
Reply to Ito.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
An Unsolved Problem of Adherence to Outpatient Parenteral Antimicrobial Therapy.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1613, doi. 10.1093/cid/ciad013
- By:
- Publication type:
- Article
Defining the Optimal Duration of Therapy for Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1604, doi. 10.1093/cid/ciad009
- By:
- Publication type:
- Article
The Last Mile Problem—Coronavirus Disease 2019 Vaccine Coverage Among the Most Socially Vulnerable.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1626, doi. 10.1093/cid/ciad006
- By:
- Publication type:
- Article
Reply to Steele et al.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Natural Antibodies and Severe Acute Respiratory Syndrome Coronavirus 2–Specific Antibodies in Healthy Asymptomatic Individuals.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
The use of Vaccinia Immune Globulin in the Treatment of Severe Mpox. Virus Infection in Human Immunodeficiency Virus/AIDS.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1671, doi. 10.1093/cid/ciac971
- By:
- Publication type:
- Article
Same-Day Treatment Following Point-of-Care Sexually Transmitted Infection Testing in Different Healthcare Settings in South Africa.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Three-Month Symptom Profiles Among Symptomatic Adults With Positive and Negative Severe Acute Respiratory Syndrome Coronavirus 2 Tests: A Prospective Cohort Study From the INSPIRE Group.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1559, doi. 10.1093/cid/ciac966
- By:
- Publication type:
- Article
Yield of Facility-based Targeted Universal Testing for Tuberculosis With Xpert and Mycobacterial Culture in High-Risk Groups Attending Primary Care Facilities in South Africa.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1594, doi. 10.1093/cid/ciac965
- By:
- Publication type:
- Article
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1615, doi. 10.1093/cid/ciad003
- By:
- Publication type:
- Article
Effectiveness and Pharmacokinetic Exposures of First-Line Drugs Used to Treat Drug-Susceptible Tuberculosis in Children: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1658, doi. 10.1093/cid/ciac973
- By:
- Publication type:
- Article
Testing for Mycoplasma genitalium and Using Doxycycline as First-Line Therapy at Initial Presentations for Non-Gonococcal Urethritis (NGU) Correlate With Reductions in Persistent NGU.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1674, doi. 10.1093/cid/ciac977
- By:
- Publication type:
- Article
The Epidemiology of Long Coronavirus Disease in US Adults.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1636, doi. 10.1093/cid/ciac961
- By:
- Publication type:
- Article
A Woman With a Complex Cystic Pelvic Mass.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Transmitted Drug Resistance to Integrase-Based First-Line Human Immunodeficiency Virus Antiretroviral Regimens in Mediterranean Europe.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1628, doi. 10.1093/cid/ciac972
- By:
- Publication type:
- Article
Reporting of Antimicrobial Resistance from Blood Cultures, an Antibacterial Resistance Leadership Group Survey Summary: Resistance Marker Reporting Practices from Positive Blood Cultures.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1550, doi. 10.1093/cid/ciac952
- By:
- Publication type:
- Article
Tuberculosis and the Risk of Ischemic Heart Disease: A Nationwide Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1576, doi. 10.1093/cid/ciac946
- By:
- Publication type:
- Article
Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1567, doi. 10.1093/cid/ciac947
- By:
- Publication type:
- Article
The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1585, doi. 10.1093/cid/ciac944
- By:
- Publication type:
- Article
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1539, doi. 10.1093/cid/ciac957
- By:
- Publication type:
- Article